Paper39735441
Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges.
Liu Z and 4 others. J Natl Cancer Cent, 2024. Cited by 24 papers, by iCite.
Cite this record
ConductScience Library. Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges. Papers, record 39735441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39735441
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Helicobacter pylori eradication for primary prevention of gastric cancer: progresses and challenges.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References165
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 14722144 | Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. | JAMA | 2004 | https://conductscience.org/library/papers/14722144 | PubMed |
| 2 | 37009691 | Cancer Progress and Priorities: Gastric Cancer. | Cancer Epidemiol Biomarkers Prev | 2023 | https://conductscience.org/library/papers/37009691 | PubMed |
| 3 | 39079993 | Gastric cancer prevention by community eradication of Helicobacter pylori: a cluster-randomized controlled trial. | Nat Med | 2024 | https://conductscience.org/library/papers/39079993 | PubMed |
| 4 | 36069529 | Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a prospective follow-up study. | Cancer Biol Med | 2022 | https://conductscience.org/library/papers/36069529 | PubMed |
| 5 | 17167474 | Inflammation and metabolic disorders. | Nature | 2006 | https://conductscience.org/library/papers/17167474 | PubMed |
| 6 | 37178702 | Molecular testing-guided therapy versus susceptibility testing-guided therapy in first-line and third-line Helicobacter pylori eradication: two multicentre, open-label, randomised controlled, non-inferiority trials. | Lancet Gastroenterol Hepatol | 2023 | https://conductscience.org/library/papers/37178702 | PubMed |
| 7 | 36789941 | Allium vegetable intake associated with the risk of incident gastric cancer: a continuous follow-up study of a randomized intervention trial. | Am J Clin Nutr | 2023 | https://conductscience.org/library/papers/36789941 | PubMed |
| 8 | 30311721 | Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers. | Helicobacter | 2018 | https://conductscience.org/library/papers/30311721 | PubMed |
| 9 | 11171812 | Blood, urine, stool, breath, money, and Helicobacter pylori. | Gut | 2001 | https://conductscience.org/library/papers/11171812 | PubMed |
| 10 | 10382128 | Randomized placebo-controlled trial of Helicobacter pylori eradication for iron-deficiency anemia in preadolescent children and adolescents. | Helicobacter | 1999 | https://conductscience.org/library/papers/10382128 | PubMed |
| 11 | 16849680 | Randomized double-blind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions. | J Natl Cancer Inst | 2006 | https://conductscience.org/library/papers/16849680 | PubMed |
| 12 | 29559361 | Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States. | Clin Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/29559361 | PubMed |
| 13 | 30145102 | The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial. | EBioMedicine | 2018 | https://conductscience.org/library/papers/30145102 | PubMed |
| 14 | 11018097 | Gastric dysplasia and gastric cancer: Helicobacter pylori, serum vitamin C, and other risk factors. | J Natl Cancer Inst | 2000 | https://conductscience.org/library/papers/11018097 | PubMed |
| 15 | 34645495 | Impact of Helicobacter pylori eradication on the gastric microbiome. | Gut Pathog | 2021 | https://conductscience.org/library/papers/34645495 | PubMed |
| 16 | 31673902 | Cost-Effectiveness Analysis of Helicobacter pylori Eradication Therapy for Prevention of Gastric Cancer: A Markov Model. | Dig Dis Sci | 2020 | https://conductscience.org/library/papers/31673902 | PubMed |
| 17 | 38572751 | Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. | CA Cancer J Clin | 2024 | https://conductscience.org/library/papers/38572751 | PubMed |
| 18 | 29990487 | Prevalence of Antibiotic Resistance in Helicobacter pylori: A Systematic Review and Meta-analysis in World Health Organization Regions. | Gastroenterology | 2018 | https://conductscience.org/library/papers/29990487 | PubMed |
| 19 | 32285569 | Helicobacter pylori "Test-and-Treat" strategy with urea breath test: A cost-effective strategy for the management of dyspepsia and the prevention of ulcer and gastric cancer in Spain-Results of the Hp-Breath initiative. | Helicobacter | 2020 | https://conductscience.org/library/papers/32285569 | PubMed |
| 20 | 21188333 | Worldwide H. pylori antibiotic resistance: a systematic review. | J Gastrointestin Liver Dis | 2010 | https://conductscience.org/library/papers/21188333 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959320 | Global burden, trends, and projections of five major upper gastrointestinal diseases, 1990-2046: an analysis of GBD 2021. | Front Public Health | 2026 | https://conductscience.org/library/papers/42959320 | PubMed |
| 42891186 | Genetically determined heterogeneous treatment effects of Helicobacter pylori eradication for targeted gastric cancer prevention. | Innovation (Camb) | 2026 | https://conductscience.org/library/papers/42891186 | PubMed |
| 42585493 | VTH BRAZILIAN CONSENSUS CONFERENCE ON HELICOBACTER PYLORI INFECTION. | Arq Gastroenterol | 2026 | https://conductscience.org/library/papers/42585493 | PubMed |
| 42446197 | Genetic susceptibility, environmental risk factors, and incident gastric cancer risk among individuals with different Helicobacter pylori infection status: a population-based study. | Cancer Biol Med | 2026 | https://conductscience.org/library/papers/42446197 | PubMed |
| 42305456 | The research progress of gastric cancer vaccines: a narrative review. | Transl Cancer Res | 2026 | https://conductscience.org/library/papers/42305456 | PubMed |
| 42032685 | LncRNA LINC01579/miR-579-3p axis promotes gastric cancer progression via NOTCH1 pathway. | World J Surg Oncol | 2026 | https://conductscience.org/library/papers/42032685 | PubMed |
| 41923851 | Investigating the Devil's tree(Alstonia scholaris) for its health-safeguardingproperty and antipathogenic activities against fungi and helminthparasites of veterinary importance. | J Adv Vet Anim Res | 2025 | https://conductscience.org/library/papers/41923851 | PubMed |
| 41531650 | Helicobacter pylori and Cancer: What's the Link? | Clin Exp Gastroenterol | 2026 | https://conductscience.org/library/papers/41531650 | PubMed |
| 41415806 | Therapeutic advances and future directions in Helicobacter pylori eradication. | Front Microbiol | 2025 | https://conductscience.org/library/papers/41415806 | PubMed |
| 41384272 | Concomitant Versus Tailored Therapy Based on Antibiotic Resistance Profiles for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis. | JGH Open | 2025 | https://conductscience.org/library/papers/41384272 | PubMed |
| 41189901 | Microbiome influence in gastric cancer progression and therapeutic strategies. | Front Med (Lausanne) | 2025 | https://conductscience.org/library/papers/41189901 | PubMed |
| 41103822 | Long-Term Proton Pump Inhibitor Therapy and Risk of Gastric Atrophy and Precancerous Mucosal Changes: A Systematic Review. | Cureus | 2025 | https://conductscience.org/library/papers/41103822 | PubMed |
| 40794596 | The global and regional burden of early-onset gastric cancer (15-49 years, 1990-2021): incidence and mortality with projections to 2030. | Oncologist | 2025 | https://conductscience.org/library/papers/40794596 | PubMed |
| 40284604 | Evaluation of the Rapid Urease Test (RUT) Device for Rapid Diagnosis of Helicobacter pylori in Middle-Aged and Elderly Taiwanese Patients. | Microorganisms | 2025 | https://conductscience.org/library/papers/40284604 | PubMed |
| 40252119 | Streptococcus anginosus: the potential role in the progression of gastric cancer. | J Cancer Res Clin Oncol | 2025 | https://conductscience.org/library/papers/40252119 | PubMed |
| 40242368 | Prevalence of HER2 expression and its association with clinicopathological parameters in gastric and gastroesophageal junction adenocarcinoma: A 10?year experience of an academic center. | Mol Clin Oncol | 2025 | https://conductscience.org/library/papers/40242368 | PubMed |
| 40242267 | Role of SMYD2 in gastrointestinal cancer progression (Review). | Oncol Lett | 2025 | https://conductscience.org/library/papers/40242267 | PubMed |
| 40231997 | Plasma L-aspartic acid predicts the risk of gastric cancer and modifies the primary prevention effect: a multistage metabolomic profiling and Mendelian randomization study. | Cancer Biol Med | 2025 | https://conductscience.org/library/papers/40231997 | PubMed |
| 39936539 | Large-scale cluster randomised trial reveals effectiveness of Helicobacter pylori eradication for gastric cancer prevention. | Clin Transl Med | 2025 | https://conductscience.org/library/papers/39936539 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39735441
GET https://conductscience.org/api/papers/v1/39735441/references?page=2